BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 33061355)

  • 1. Serum Amyloid A in Stable COPD Patients is Associated with the Frequent Exacerbator Phenotype.
    Zhao D; Abbasi A; Rossiter HB; Su X; Liu H; Pi Y; Sang L; Zhong W; Yang Q; Guo X; Zhou Y; Li T; Casaburi R; Zhang N
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2379-2388. PubMed ID: 33061355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Airway Thickening and Serum Cytokines in COPD Patients with Frequent Exacerbations: A Heart of the Matter.
    Lin Y; Sang L; Wang J; Chen Y; Lai J; Zhu X; Yang Y; Zhang Z; Liu Y; Wen S; Zhang N; Zhao D
    Int J Chron Obstruct Pulmon Dis; 2023; 18():2353-2364. PubMed ID: 37928768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sputum microbiome α-diversity is a key feature of the COPD frequent exacerbator phenotype.
    Pragman AA; Hodgson SW; Wu T; Zank A; Reilly CS; Wendt CH
    ERJ Open Res; 2024 Jan; 10(1):. PubMed ID: 38333651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease.
    Wedzicha JA; Brill SE; Allinson JP; Donaldson GC
    BMC Med; 2013 Aug; 11():181. PubMed ID: 23945277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A predictive model for frequent exacerbator phenotype of acute exacerbations of chronic obstructive pulmonary disease.
    Zhang Y; Zheng SP; Hou YF; Jie XY; Wang D; Da HJ; Li HX; He J; Zhao HY; Liu JH; Ma Y; Qiang ZH; Li W; Zhang M; Shan H; Wu YY; Shi HY; Zeng L; Sun X; Liu Y
    J Thorac Dis; 2023 Dec; 15(12):6502-6514. PubMed ID: 38249857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood eosinophils levels in a Colombian cohort of biomass-and tobacco-related COPD patients.
    García Morales OM; Cañas-Arboleda A; Rodríguez Malagón MN; Galindo Pedraza JL; Rodríguez Torres P; Avendaño Morales VR; González-Rangel AL; Celis-Preciado CA
    Front Med (Lausanne); 2024; 11():1321371. PubMed ID: 38803343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum metabolomics analysis of patients with chronic obstructive pulmonary disease and 'frequent exacerbator' phenotype.
    Ding HZ; Wang H; Wu D; Zhou FC; Zhu J; Tong JB; Gao YT; Li ZG
    Mol Med Rep; 2024 Aug; 30(2):. PubMed ID: 38873983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of serum surfactant protein D as a biomarker of exacerbation of chronic obstructive pulmonary disease.
    Zien Alaabden A; Mohammad Y; Fahoum S
    Qatar Med J; 2015; 2015(2):18. PubMed ID: 26942111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of Serum Clara Cell Secretory Protein 16, Plasma Fibrinogen and Serum Amyloid A with the Severity of Acute Exacerbated COPD and Their Combination in Prognosis Assessment.
    Hu X; Xu J; Li P; Zheng H
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1949-1957. PubMed ID: 37700931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and multimodal characterization of an elastase-induced emphysema mouse disease model for the COPD frequent bacterial exacerbator phenotype.
    Rodríguez-Arce I; Morales X; Ariz M; Euba B; López-López N; Esparza M; Hood DW; Leiva J; Ortíz-de-Solórzano C; Garmendia J
    Virulence; 2021 Dec; 12(1):1672-1688. PubMed ID: 34252004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?
    Sadatsafavi M; McCormack J; Petkau J; Lynd LD; Lee TY; Sin DD
    Eur Respir J; 2021 Feb; 57(2):. PubMed ID: 32855228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Study of Systemic Inflammatory Markers in Clinical Phenotypes of Chronic Obstructive Pulmonary Disease.
    Sonar M; Jayadeva BT; Shashibhushan BL
    Tanaffos; 2023 Feb; 22(2):215-220. PubMed ID: 38628879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Proteomics Study Between the Frequent Exacerbation and Infrequent Exacerbation Phenotypes of Chronic Obstructive Pulmonary Disease.
    Yang C; Yang L; Yang L; Li S; Ye L; Ye J; Chen C; Zeng Y; Zhu M; Lin X; Peng Q; Wang Y; Jin M
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1713-1728. PubMed ID: 37581107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway transcriptome networks identify susceptibility to frequent asthma exacerbations in children.
    Phelan KJ; Dill-McFarland KA; Kothari A; Segnitz RM; Burkle J; Grashel B; Jenkins S; Spagna D; Martin LJ; Haslam DB; Biagini JM; Kalra M; McCoy KS; Ross KR; Jackson DJ; Mersha TB; Altman MC; Khurana Hershey GK
    J Allergy Clin Immunol; 2023 Jul; 152(1):73-83. PubMed ID: 36918038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant protein D, a clinical biomarker for chronic obstructive pulmonary disease with excellent discriminant values.
    Akiki Z; Fakih D; Jounblat R; Chamat S; Waked M; Holmskov U; Sorensen GL; Nadif R; Salameh P
    Exp Ther Med; 2016 Mar; 11(3):723-730. PubMed ID: 26997985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unravelling the "frequent exacerbator" phenotype in cystic fibrosis.
    Cohen R; Shteinberg M
    Eur Respir J; 2024 Feb; 63(2):. PubMed ID: 38388000
    [No Abstract]   [Full Text] [Related]  

  • 17. COPD: systemic proteomic profiles in frequent and infrequent exacerbators.
    Enríquez-Rodríguez CJ; Casadevall C; Faner R; Castro-Costa A; Pascual-Guàrdia S; Seijó L; López-Campos JL; Peces-Barba G; Monsó E; Barreiro E; Cosío BG; Agustí A; Gea J;
    ERJ Open Res; 2024 Mar; 10(2):. PubMed ID: 38529348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CCL-18 and CX3CL1 in Serum, and Their Potential Roles as Two Diagnostic and Prognostic Markers in Chronic Obstructive Pulmonary Disease and Chronic cor Pulmonale (COPD&CCP): a Pilot Study.
    Xu QH; Huang SP; Li WL; Ye XY; Lin XH; Wu YL; Chen XF; Zhuang XB
    Clin Lab; 2020 Oct; 66(10):. PubMed ID: 33073965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Cluster Analysis for COPD Including Systemic and Airway Inflammatory Markers.
    Zahraei HN; Guissard F; Paulus V; Henket M; Donneau AF; Louis R
    COPD; 2020 Dec; 17(6):672-683. PubMed ID: 33092418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood eosinophil and neutrophil counts differentially identify frequent exacerbation in patients with COPD with physician-diagnosed asthma and COPD.
    Mochimaru T; Chubachi S; Irie H; Sakurai K; Okuzumi S; Sunata K; Masaki K; Miyata J; Nakamura H; Asano K; Fukunaga K
    Allergol Int; 2021 Apr; 70(2):255-257. PubMed ID: 33087300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.